Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation
Launched by OTSUKA PAKISTAN LIMITED · Jun 23, 2010
Trial Information
Current as of August 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with dyspepsia or epigastric pain and endoscopically proven gastric and duodenal ulcers
- • Required laboratory parameters and time limits (screening blood tests will be taken including hemoglobin, white blood cell count, random glucose, potassium, sodium, chlorine, creatinine, AST, ALT, bilirubin, and alkaline phosphatase)
- • Age \> 18 years
- • A statement that all patients must have signed an informed consent form prior to registration in study
- Exclusion Criteria:
- • Patients who had undergone surgery for ulcers
- • History of hypersensitivity to drugs to be used in the study
- • Women who are pregnant or lactating or intended to get pregnant during the study period
About Otsuka Pakistan Limited
Otsuka Pakistan Limited is a leading pharmaceutical company dedicated to improving health outcomes through innovative research and development. As a subsidiary of Otsuka Pharmaceutical Co., Ltd., a global healthcare enterprise, Otsuka Pakistan focuses on providing high-quality therapeutic solutions across various therapeutic areas, including psychiatry, neurology, and nephrology. With a commitment to advancing medical science and enhancing patient care, Otsuka Pakistan actively participates in clinical trials and collaborates with healthcare professionals to facilitate groundbreaking studies that contribute to the development of effective treatments and therapies. Through its endeavors, Otsuka Pakistan aims to address unmet medical needs and enhance the quality of life for patients in Pakistan and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, , Pakistan
Karachi, , Pakistan
Karachi, , Pakistan
Patients applied
Trial Officials
Dr. Laeeque Ahmed, Asst. Professor
Principal Investigator
Dr. Ziauddin University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials